Item 8.01 Other Events
On each of January 8, 2020 and January 21, 2020, TransEnterix, Inc., a Delaware
corporation (the "Company"), issued a press release announcing its entry into an
agreement to lease its Senhance® System to an additional hospital customer.
On January 14, 2020, the Company issued a press release to announce it had filed
a 510(k) submission with the U.S. Food and Drug Administration for its
Intelligent Surgical Unit (ISU™) for use with the Senhance System. The Company
believes it is the first such FDA submission seeking clearance for machine
vision technology in abdominal robotic surgery. A copy of the press releases are
filed herewith as Exhibit 99.1, Exhibit 99.2 and Exhibit 99.3 and incorporated
herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. Description
99.1 Press Release, dated January 8, 2020
99.2 Press Release, dated January 14, 2020
99.3 Press Release, dated January 21, 2020
2
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses